<DOC>
	<DOCNO>NCT00970463</DOCNO>
	<brief_summary>To test hypothesis lack excess growth hormone ( GH ) associate cardiac abnormality . Cardiac function morphology evaluate MRI treatment .</brief_summary>
	<brief_title>Cardiac Function Morphology Evaluated Magnetic Resonance Imaging Growth Hormone Deficiency Acromegaly</brief_title>
	<detailed_description>It open prospective noninterventional clinical study . Treatment follow-up accord usual guideline , unaffected inclusion study . GHD patient treat daily subcutaneous GH injection . Patients acromegaly treat either transsphenoidal surgery medical treatment long act somatostatin analogue , dopamine agonist , GH antagonist combination treatment modality . Patients examine Cardiac MRI treatment one year treatment .</detailed_description>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Acromegaly</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Peak GH 6.0 ng/mL PyridostigmineGHRH test . Nadir GH 0.4 ng/mL elevated level IGFI oral glucose tolerance test Contraindications magnetic resonance scan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>The GH-system cardiac function</keyword>
</DOC>